2026 NPPES data Dermatology Physician NPI 1033323258 MD
Verify on CMS →

ROBERT WOODBURY, MD

Dermatology Physician in RIVERSIDE, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 885 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
96%
generic claims · 4% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
99.3256/100
▲ 16 pts above national avg 83.1 · [object Object]
Industry payments
$226.01
3 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ROBERT WOODBURY, MD reported a CMS MIPS final score of 99.3256/100 — above the 83.1 national average — and filed 2,418 Medicare Part D claims in 2023.

99.3256/100
MIPS score · +16 vs avg
2K
Part D claims, 2023
96%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ROBERT WOODBURY, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

99 Top 9% higher than 91% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

ROBERT WOODBURY, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ROBERT WOODBURY, MD?

High performer (top quartile)

NPI registry status

Active

Issued 05/09/2007

NPI 1033323258

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

2,418 232% vs specialty avg

2023 prescription claims

Specialty avg: 729

MIPS final score

99.3256/100 16.2256% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Connecticut

How Dermatology Physician compares to other specialties among Connecticut providers

Connecticut providers

Dermatology Physician share within Connecticut

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within Connecticut

Medicare quality performance — MIPS

ROBERT WOODBURY, MD's 2023 MIPS final score plotted against the Dermatology Physician national average

High performer (top quartile)
MIPS Final Score
99.3256/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatology Physician) — 99.3256/100 vs national avg 83.1

0%100%National avg83%99%
MIPS final score (Dermatology Physician) — 99.3256/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROBERT WOODBURY, MD appears in the CMS NPPES registry as a Dermatology Physician provider holding MD credentials at 1200 E PUTNAM AVE, RIVERSIDE, CT, 06878, with a listed phone of (203) 637-8114. NPI 1033323258 was issued on 05/09/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WOODBURY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 2,418 prescription claims written by this provider, covering 885 Medicare beneficiaries and totaling roughly $149K in drug spend, split 4% brand-name and 96% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 99.3256/100 for the 2023 performance year (Quality 98.6513), compared with the national average of 83.1.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1200 E PUTNAM AVE
RIVERSIDE, CT 06878

Provider Details

NPI 1033323258
Specialty Dermatology Physician
Credentials MD
Gender Male
NPI Issued 05/09/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

99.3256
Final Score
Avg: 83.1
98.6513
Quality

Reporting: Individual

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ROBERT WOODBURY, MD. Source: openpaymentsdata.cms.gov.

Total received

$226

Largest payer

Janssen Biotech, Inc.

Most common payment type

Education

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

ROBERT WOODBURY, MD — brand share 4.0%
Specialty average (est.)

4% brand-name claims vs 96% generic, on 2,418 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

2,418
Total Claims
$149K
Total Drug Cost
885
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,513
Total Day Supply
56,032
Brand vs Generic
4% brand / 96% generic
Brand Drug Cost
$66K
Generic Drug Cost
$83K
Antibiotic Claims
243

Patient Demographics

Average Patient Age
75.2 years
Avg HCC Risk Score
1.01
Gender Split
51% female / 49% male
Age Distribution
<65: 59, 65-74: 334, 75-84: 354, 85+: 138

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ROBERT WOODBURY, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Ciclopirox
Ciclopirox Olamine
317
Triamcinolone Acetonide
301
Betamethasone Dipropionate
259
Mupirocin
167
Ketoconazole
156
Clindamycin Phosphate
130
Fluocinonide
113
Metronidazole
112
Minocycline Hcl
94
Valacyclovir
Valacyclovir Hcl
81

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How ROBERT WOODBURY, MD fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

ROBERT WOODBURY, MD's 2,418 claims are above the specialty average of 729.

Nearby Dermatology Physician Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as WOODBURY.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROBERT WOODBURY, MD's specialty?
ROBERT WOODBURY, MD specializes in Dermatology Physician and practices in RIVERSIDE, Connecticut. Credentials: MD.
How much does ROBERT WOODBURY, MD prescribe under Medicare Part D?
In 2023, ROBERT WOODBURY, MD wrote 2,418 Medicare Part D claims totaling $149K in drug costs for 885 beneficiaries.
What is ROBERT WOODBURY, MD's Medicare quality score?
ROBERT WOODBURY, MD has a CMS MIPS Final Score of 99.3256/100 (Quality: 98.6513). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is ROBERT WOODBURY, MD located?
ROBERT WOODBURY, MD is located at 1200 E PUTNAM AVE, RIVERSIDE, CT, 06878. Phone: (203) 637-8114.
What is ROBERT WOODBURY, MD's NPI number?
ROBERT WOODBURY, MD's National Provider Identifier (NPI) is 1033323258, issued on 05/09/2007.
Does ROBERT WOODBURY, MD prescribe more brand-name or generic drugs?
ROBERT WOODBURY, MD's prescribing is 4% brand-name and 96% generic drugs by claim count, with $66K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does ROBERT WOODBURY, MD prescribe most often?
Based on 2023 Medicare Part D data, ROBERT WOODBURY, MD's most frequently prescribed drugs include Ciclopirox, Triamcinolone Acetonide, Betamethasone Dipropionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROBERT WOODBURY, MD accept Medicare?
ROBERT WOODBURY, MD appears in CMS Medicare data with 2,418 Part D claims and 885 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROBERT WOODBURY, MD's credentials?
ROBERT WOODBURY, MD's NPI is 1033323258 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology